SU-Holdings Co.,Ltd. (KOSDAQ: 031860)

Market Cap	18.49B
Revenue (ttm)	12.29B
Net Income (ttm)	-19.44B
Shares Out	15.02M
EPS (ttm)	-1,554.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,434
Open	1,204.00
Previous Close	1,204.00
Day's Range	1,198.00 - 1,275.00
52-Week Range	174.00 - 3,165.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About SU-Holdings Co.,Ltd.

SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd. and changed its name to SU-Holdings Co.,Ltd. in July 2023. SU-Holdings Co.,Ltd. was founded in 1979 and is based in Seoul, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 18
• Stock Exchange: KOSDAQ
• Ticker Symbol: 031860

Financial Performance

In 2023, SU-Holdings Co.,Ltd.'s revenue was 11.31 billion, an increase of 35.46% compared to the previous year's 8.35 billion. Losses were -31.73 billion, 118.7% more than in 2022.